Matthias Eggenstein et al.
COMMUNICATIONS
due was recrystallised from toluene/ethanol affording the
product with a purity of 88% based on 31P NMR; yield:
236 mg (66%). Analytically pure product was obtained after
a second recrystallisation; yield: 19 mg (5%). 1H NMR
(600 MHz, CD2Cl2): d=2.04 (br, 3H, CH3), 5.48 (br, 1H,
CH), 6.38 (br, 2H, Ar), 6.69 (br, 1H, Ar), 6.92 (br, 1H, Ar)
7.81–6.69 (m, 28H, Ar), 8.26 (br, 1H, Ar); 13C NMR
(150 MHz, CD2Cl2): d=23.5 (d, J=26.9 Hz, CH3), 60.2
(CH), 122.4 (Ar, CH), 123.2 (Ar, CH), 125.3 (Ar, CH),
125.9 (Ar, CH), 126.3 (Ar, CH), 126.5 (Ar, CH), 126.8 (Ar,
CH), 127.2 (Ar, CH), 127.4 (Ar, CH), 128.3 (Ar, CH), 128.4
(Ar, CH), 128.6 (Ar, CH), 128.8 (Ar, CH), 129.0 (Ar, CH),
129.2 (Ar, CH), 129.3 (Ar, CH), 129.9 (Ar, CH), 130.7 (Ar,
CH), 130.9 (Ar, Cq), 131.1 (Ar, CH), 131.9 (Ar, Cq), 133.1
(d, J=12.6 Hz, Ar, Cq), 133.6 (d, J=19.6 Hz, Ar, CH), 134.3
(Ar, Cq), 134.5 (d, J=19.6 Hz, Ar, CH), 136.7 (Ar, CH),
138.6 (Ar, Cq), 138.8 (d, J=12.6 Hz, Ar, Cq), 139.3 (Ar, Cq),
140.5 (Ar, Cq) 150.0 (Ar, Cq), 150.3 (Ar, Cq); 31P{1H}-NMR
(121 MHz, CDCl3): d=À17.2 (br), 138.4 (br); MS (EI): m/z
(%)=745 (M+, 1), 448 (11), 447 (34), 433 (26), 432 (100),
431 (50), 430 (12), 416 (23), 287 (19), 286 (100), 268 (13),
257 (13), 239 (16), 155 (12); HR-MS (ESI): m/z=745.23021,
calcd. for C50H37NO2P2: 745.22941; [a]2D0: +166.3 (c 0.51,
CH2Cl2).
HR-MS (ESI): m/z=745.22966, calcd. for C50H37NO2P2:
745.22941; [a]2D0: À83.3 (c 0.47, CH2Cl2).
Synthesis of (11bS)-N-[2-(Diphenylphosphino)phen-
yl]-N-[(S)-1-(naphthalen-1-yl)ethyl]-8,9,10,11,
12,13,14,15-octahydrodinaphtho[2,1-d:1’,2’-f]
AHCTUNGRTEN[GNUN 1,3,2]dioxaphosphepin-4-amine [(Sa,Sc)-2]
The title compound was obtained by the procedure de-
scribed above using toluene as the solvent, (S)-4a and a
slight excess (1.1 equiv.) of n-butyllithium, TMEDA and
(S)-6. The pure product was obtained after one recrystallisa-
tion from toluene/ethanol; yield: 37% Two sets of signals in
a ratio of 1.26:1 were observed in 31P NMR due to two ro-
tamers (referred to below as major and minor). For the
same reason broad signals were observed partly in the
1H NMR spectrum. 1H NMR (400 MHz, CDCl3): d=1.22–
1.76 (m, 11H, CH3/CH2), 2.03 (m, 2H, CH2), 2.43 (m, 2H,
CH2), 2.68 (m, 4H, CH2), 4.46 (br, 1H, CH), 6.09 (br, 1H,
Ar), 6.47 (br, 1H, Ar), 6.72 (br, 1H, Ar), 6.79–7.23 (m,
16H, Ar); 13C NMR (100 MHz, CD2Cl2): d=23.0, 27.8, 28.1,
29.4, 29.5, 60.2, 118.9, 119.6, 126.7, 127.5, 128.1, 128.4,
128.48, 128.51, 128.57, 128.6, 128.8, 128.9, 129.0, 129.2, 129.4,
129.5, 133.4, 133.9, 138.1, 138.6, 138.7, 139.5, 139.6, 149.0;
31P{1H}-NMR (125 MHz, CDCl3): d=À17.1, 136.2 (major);
À17.1, 135.9 (minor); MS (EI): m/z (%)=703.1 (M, 1), 382
(12), 381 (15), 380 (11), 337 (27), 183 (22), 92 (65), 91 (100);
HR-MS (ESI): m/z=703.27555, calcd. for C44H39O2NP2:
703.27636; [a]2D0: +30.3 (c 0.48, CH2Cl2).
Synthesis of (11bR)-N-[2-(Diphenylphosphino)-
phenyl]-N-[(S)-1-(1-naphthyl)ethyl]dinaphtho[2,1-
d:1’,2’-f]ACHTUNGTRENNUNG[1,3,2]dioxaphosphepin-4-amine [(Ra,Sc)-1b]
The title compound was obtained by the procedure de-
scribed above using (R)-5 instead of (S)-5; yield: 44%,
purity: 94% based on 31P NMR. An analytical pure sample
was obtained after a second recrystallisation; yield: 7%.
Two sets of signals in a ratio of 1.3:1 were observed in the
1H, 13C NMR and 31P NMR spectra due to two rotamers (re-
ferred to below as major and minor). Major: 1H NMR
(600 MHz, CD2Cl2): d=1.77 (br, 3H, CH3), 5.62 (br, 1H,
CH), 6.92 (br, 2H, Ar, major), 7.05–8.08 (m, 31H, Ar);
31P{1H}-NMR (250 MHz, CDCl3): d=À19.4 (d, J=32.1 Hz),
Synthesis of (11bR)-N-[2-(Diphenylphosphino)phen-
yl]-N-phenyldinaphtho[2,1-d:1’,2’-f][1,3,2]dioxaphos-
phepin-4-amine [(Ra)-1c]
The title compound was obtained by the procedure de-
scribed above using THF as the solvent, N-phenyl-2-diphe-
nylphosphinoaniline 4c (706 mg, 2.0 mmol) and (R)-5
(700 mg, 2.0 mmol). The crude product was purified by re-
crystallisation from toluene/ethanol; yield: 59%; white crys-
1
1
talline solid. H NMR (600 MHz, CDCl3): d=6.85 (m, 1H,
140.3 (d, J=32.1 Hz). Minor: H NMR (600 MHz, CD2Cl2):
Ar), 6.88–7.01 (m, 6H, Ar), 7.08 (m, 1H, Ar), 7.13–7.44 (m,
19H, Ar), 7.67 (d, J=8.7 Hz, 1H, Ar), 7.84 (d, J=8.7 Hz,
1H, Ar), 7.85 (d, J=8.2 Hz, 1H, Ar), 7.89 (d, J=8.7 Hz,
1H, Ar); 13C{1H}-NMR (150 MHz, CDCl3): d=121.8, 122.0,
122.2, 122.6, 124.3 (d, J=4.5 Hz), 124.8 (d, J=56.9 Hz),
125.9 (d, J=33.7 Hz), 127.1 (d, J=34.3 Hz), 127.3, 128.3 (d,
J=14.2 Hz), 128.4, 128.55 (d, J=16.8 Hz), 128.58, 128.7,
129.6, 130.23, 130.25, 131.2 (d, J=116.6 Hz), 132.8 (d, J=
34.4 Hz), 133.8 (d, J=18.8 Hz), 134.1 (d, J=19.9 Hz), 135.9,
138.0 (dd, J=159.1 Hz, 11.1 Hz), 138.2 (d, J=12.5 Hz),
145.6 (d, J=11.0 Hz), 147.4 (dd, J=27.0 Hz, 6.2 Hz), 148.8,
149.9; 31P{1H}-NMR (250 MHz, CDCl3): d=À15.5 (d, J=
34.7 Hz), 141.4 (d, J=34.7 Hz); MS (EI): m/z (%)=667
(M+, 93), 590 (100), 527 (17), 352 (26), 315 (12), 299 (12),
275 (11), 274 (14), 268 (25), 252 (12), 198 (12), 183 (10);
HR-MS (ESI): m/z=668.190283 (C44H32NO2P2), calcd. for
(M+H)+: 668.189413; [a]D20: À78.1(c 0.56, CH2Cl2).
d=1.70 (br, 3H, CH3), 5.96 (br, 1H, CH), 6.24 (br, 1H, Ar),
6.74 (br, 1H, Ar), 6.98 (br, 2H, Ar), 7.05–7.94 (m, 28H,
Ar), 8.21 (br, 1H, Ar); 31P{1H}-NMR (250 MHz, CDCl3):
d=À17.1 (d, J=16.4 Hz), 141.8 (d, J=16.4 Hz); 13C NMR
(150 MHz, CD2Cl2): d=22.9 (CH3, minor), 23.9 (CH3,
major) 53.3 (CH, minor), 56.7 (CH, major), 121.6 (Ar, Cq),
122.3 (Ar, CH), 122.5 (Ar, CH), 122.8 (Ar, CH), 123.1 (Ar,
CH), 123.7 (Ar, CH), 124.2 (Ar, Cq), 124.8 (Ar, CH), 125.0
(Ar, CH), 125.2 (Ar, CH), 125.3 (Ar, CH), 125.4 (Ar, CH),
125.6 (Ar, CH), 126.0 (Ar, CH), 126.3 (Ar, CH), 126.4 (Ar,
CH), 126.7 (Ar, CH), 127.2 (Ar, CH), 127.4 (Ar, CH), 127.7
(Ar, CH), 127.9 (Ar, CH), 128.5 (Ar, CH), 128.7 (Ar, CH),
128.9 (Ar, CH) 129.1 (Ar, CH), 129.8 (Ar, CH), 129.9 (Ar,
CH), 130.4 (Ar, CH), 130.8 (Ar, Cq), 131.0 (Ar, CH), 131.2
(Ar, Cq), 131.5 (Ar, Cq), 131.8 (Ar, Cq), 132.1 (Ar, Cq), 133.1
(Ar, Cq), 133.4 (Ar, CH), 133.9 (d, J=20 Hz, Ar, CH), 134.2
(d, J=20 Hz, Ar, CH), 134.6 (d, J=20 Hz, Ar, CH), 135.2
(Ar, CH), 137.1 (Ar, CH), 138.3 (Ar, Cq), 139.1 (Ar, Cq),
139.6 (Ar, Cq), 140.1 (Ar, Cq), 149.6 (Ar, Cq), 150.3 (Ar, Cq),
151.2 (Ar, Cq); MS (EI): m/z (%)=745 (M+, 3), 448 (33),
447 (100), 433 (12), 431 (81), 430 (27), 417 (11), 416 (33),
287 (18), 286 (100), 268 (21), 257 (12), 239 (12), 155 (10);
Synthesis of [RhACHTUNRTGENNG(U COD)AHCUTNGTRNE{NUNG (Sa,Sc)-1a}] BF4
To a solution of [Rh
ACHUTNGTRENNUG(COD)ACHTUNGTRNE(NUGN acac)] (0.1 mmol, 31.2 mg) in
THF (2 mL), HBF4·Et2O (0.1 mmol, 13.6 mL) was added at
730
ꢂ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2009, 351, 725 – 732